AI assistant
Sending…
Aquestive Therapeutics, Inc. — Director's Dealing 2021
Jun 1, 2021
32552_dirs_2021-06-01_a64d91db-cbde-4af1-a298-0ea0d86ef710.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Aquestive Therapeutics, Inc. (AQST)
CIK: 0001398733
Period of Report: 2021-05-10
Reporting Person: Cochran John (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-10 | Common Stock | G | 37500 | — | Disposed | 99486 | Direct |
Footnotes
F1: The reporting person gifted these shares of Common Stock to Event Facilities Fort Worth Inc. for no consideration.
F2: Price is not applicable to acquisitions or dispositions resulting from bona fide gifts.
More from Aquestive Therapeutics, Inc.
Annual Report
2026
Apr 24
Regulatory Filings
2026
Mar 30
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Feb 26
Regulatory Filings
2026
Feb 2
Regulatory Filings
2026
Jan 21
Regulatory Filings
2026
Jan 9
Director's Dealing
2025
Dec 5
Director's Dealing
2025
Dec 4
Regulatory Filings
2025
Nov 17